The Aging Research Funding Framework
Optimizing funding for aging research
This framework provides a structured approach to optimizing funding for aging research, highlighting the importance of a balance between public and private funding and the need to define aging as a disease.
- Aging is a disease that can be treated and reversed
- Public funding is essential for advancing aging research
- Private investment can drive innovation and competition in the field
- Assess current funding levels for aging researchEvaluate the current level of funding for aging research and compare it to other diseasesPro tipThis step can help to identify areas for improvement and opportunities for increased fundingWarningThis step may require careful consideration of the potential risks and benefits
- Advocate for increased public funding for aging researchSupport increased public funding for aging research, to drive innovation and progress in the fieldPro tipThis step can help to accelerate progress and bring new therapies to marketWarningThis step may require significant investment and resources
- Encourage private investment in aging researchSupport private investment in aging research, to drive innovation and competition in the fieldPro tipThis step can help to accelerate progress and bring new therapies to marketWarningThis step may require careful consideration of the potential risks and benefits
The National Institute on Aging is a division of the NIH that focuses on aging research, but its budget is limited and its focus is often on individual diseases rather than the biology of aging
Private investment in aging research can drive innovation and competition in the field, but it can also be limited by a focus on short-term gains rather than long-term progress
The framework is based on the author's experience as a researcher and policymaker in the field of aging, and his observation of the lack of funding for aging research compared to other diseases.